Basic Amino Acids at the C‐Terminus of the Third Intracellular Loop Are Required for the Activation of Phospholipase C by Cholecystokinin‐B Receptors
暂无分享,去创建一个
[1] M. Sukumar,et al. G protein-bound conformation of mastoparan-X, a receptor-mimetic peptide. , 1992, The Journal of biological chemistry.
[2] S. Jayadev,et al. Identification of a Domain in the Angiotensin II Type 1 Receptor Determining Gq Coupling by the Use of Receptor Chimeras (*) , 1995, The Journal of Biological Chemistry.
[3] J. Rehfeld,et al. Molecular Forms of Cholecystokinin in the Brain and the Relationship to Neuronal Gastrins a , 1985, Annals of the New York Academy of Sciences.
[4] T. Katada,et al. A simple structure encodes G protein-activating function of the IGF-II/mannose 6-phosphate receptor , 1990, Cell.
[5] Hung-Li Wang,et al. Gαq/11 Mediates Cholecystokinin Activation of the Cationic Conductance in Rat Substantia Nigra Dopaminergic Neurons , 1996, Journal of neurochemistry.
[6] M. Berridge,et al. Inositol trisphosphate and calcium signaling. , 1988, Cold Spring Harbor symposia on quantitative biology.
[7] R. Jensen,et al. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Neubig,et al. Two peptides from the alpha 2A-adrenergic receptor alter receptor G protein coupling by distinct mechanisms. , 1991, The Journal of biological chemistry.
[9] I. Nishimoto,et al. Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. , 1992, The Journal of biological chemistry.
[10] A. Weerth,et al. The brain and gastrointestinal cholecystokinin receptor family; structure and functional expression , 1992, Regulatory Peptides.
[11] M. Caron,et al. Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function. , 1992, Annual review of pharmacology and toxicology.
[12] J. Wess,et al. Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover , 1989, FEBS letters.
[13] A. Trzeciak,et al. Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[14] B. Roques,et al. Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction. , 1995, Molecular pharmacology.
[15] Y. Kurosawa,et al. A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction. , 1991, Gene.
[16] M. Goiny,et al. On the Origin of Striatal Cholecystokinin Release: Studies with In Vivo Microdialysis , 1994, Journal of Neurochemistry.
[17] L. F. Kolakowski,et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Nakanishi,et al. Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.
[19] R. Chang,et al. Ligands for Cholecystokinin A and Cholecystokinin B/Gastrin Receptors , 1991 .
[20] S. Nakanishi,et al. Molecular characterization of a functional cDNA for rat substance P receptor. , 1989, The Journal of biological chemistry.
[21] E. Peralta,et al. Charged amino acids required for signal transduction by the m3 muscarinic acetylcholine receptor. , 1993, The EMBO journal.
[22] B. Cullen. Use of eukaryotic expression technology in the functional analysis of cloned genes. , 1987, Methods in enzymology.
[23] J. Burnier,et al. Regulation of Gi and G,, by Mastoparan, Related Amphiphilic Peptides, and Hydrophobic Amines , 1990 .
[24] P. Godfrey. Methods for the Analysis of Phosphoinositides and Inositol Phosphates , 1992 .
[25] J. Wess,et al. Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[26] B. Kobilka,et al. Adrenergic receptors as models for G protein-coupled receptors. , 1992, Annual review of neuroscience.
[27] S. Yamagishi,et al. Rat brain glutamate receptors activate chloride channels in Xenopus oocytes coupled by inositol trisphosphate and Ca2+. , 1989, The Journal of physiology.
[29] J. Rehfeld,et al. Distribution of Cholecystokinin‐Like Peptides in the Human Brain , 1982, Journal of neurochemistry.
[30] C. Fraser,et al. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors. , 1996, Molecular pharmacology.
[31] B. Costall,et al. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[32] R. Lefkowitz,et al. Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. , 1994, The Journal of biological chemistry.
[33] R. Jensen,et al. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes. , 1994, Molecular pharmacology.
[34] J. Crawley. Comparative Distribution of Cholecystokinin and Other Neuropeptides , 1985, Annals of the New York Academy of Sciences.
[35] C. Fraser,et al. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.